In vitro evaluation of 5-Fluorouracil release by microspheres based on chitosan / Montmorillonite/ Avaliação in vitro da libertação de 5-Fluorouracil por microesferas à base de quitosano / Montmorilonite

• Autor(a) principal: Barbosa, Hanniman Denizard Cosme
• Data de Publicação: 2020
• Outros Autores: Santos, Bárbara Fernanda Figueiredo dos, Tavares, Albaniza Alves, Andrade, Magno Duran Silva de, Ferreira, Raony de Melo, Sousa, João Marçal Medeiros de, Moura, Clayton Leite de, Silva, Suédina Maria de Lima
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Revista Veras
• Texto Completo: https://ojs.brazilianjournals.com.br/ojs/index.php/BRJD/article/view/22043
• topic: Chitosan; 5-Fluorouracil; microspheres; controlled release.

5-fluorouracil (5-FU) is one of the most widely used chemotherapeutic compounds for cancer treatment and its rapid metabolization and non-uniform oral absorption are the limitations for its use as an oral chemotherapy. Therefore, this study was performed to evaluate the influence of a 5-fluorouracil (5-FU) nanocomposite microspheres with different diameters to test on a controlled release system in the gastrointestinal environment. 5-FU was incorporated into the chitosan/montmorillonite nanocomposite microspheres through the intercalation method. The microspheres containing the 5-FU were characterized by X-ray diffraction (XRD), scanning electron microscopy (SEM) and optical microscopy (OM). In vitro release fractions at different pHs (1.2, 7.4 and 10.0) were investigated by UV-vis spectroscopy. The release profile of 5-FU for the systems studied was adjusted through the Korsmeyer-Peppas kinetic model, and the results suggested that the mechanism of controlled release at pH 7.4 and 10 occurs by diffusion. In addition, the 5-FU microspheres diameter and roughness directly interfere with the release rate and the released fraction, since the F1 / F2 systems showed a difference in the released fraction of 5-FU of 7.97% and for the systems F3 / F4 the difference was 2.86%. The prepared F1, F2, F3 and F4 systems are suitable for delivery of 5-FU to the gastrointestinal environment in a controlled manner.